Penumbra (PEN) Cash & Equivalents (2014 - 2026)

Penumbra's (PEN) quarterly Cash & Equivalents came in at $241.3 million in Q1 2026, down 35.84% year-on-year from $376.1 million in Q1 2025, and up 29.1% on a QoQ basis from $186.9 million in Q4 2025.

Penumbra (PEN) Cash & Equivalents (2014 - 2026) Analysis & Trends

Penumbra (PEN) has 13 years of Cash & Equivalents data on file, last reported at $241.3 million in Q1 2026.

  • On a quarterly basis, Cash & Equivalents fell 35.84% year-over-year to $241.3 million in Q1 2026; TTM through Mar 2026 was $241.3 million, a 35.84% decrease from a year earlier, with the FY2025 full-year figure at $186.9 million, down 42.39% from the prior year.
  • Cash & Equivalents for Q1 2026 stood at $241.3 million, up from $186.9 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for PEN reached as high as $421.8 million in Q2 2025 and fell as low as $54.8 million in Q3 2022.
  • Historically, Cash & Equivalents has averaged $199.5 million across 5 years, with a median of $186.9 million in 2025.
  • Across the five-year window, Cash & Equivalents jumped 178.37% in 2024 and plunged 42.39% in 2025, its largest moves.
  • Year by year, Cash & Equivalents stood at $69.9 million in 2022, then soared by 139.75% to $167.5 million in 2023, then surged by 93.69% to $324.4 million in 2024, then plunged by 42.39% to $186.9 million in 2025, then advanced by 29.1% to $241.3 million in 2026.
  • Per Business Quant data, the three most recent Cash & Equivalents figures were $241.3 million in Q1 2026, $186.9 million in Q4 2025, and $321.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 6.80 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 2.88 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 1.95 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 1.45 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 2.45 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 1.12 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 3.03 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 2.29 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 557.00 Mn
10 Penumbra 12.48 Bn 11.87 Bn 253.41 Mn 241.29 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 241.29 Mn
Dec 31, 2025 186.90 Mn
Sep 30, 2025 321.03 Mn
Jun 30, 2025 421.77 Mn
Mar 31, 2025 376.05 Mn
Dec 31, 2024 324.40 Mn
Sep 30, 2024 280.48 Mn
Jun 30, 2024 288.33 Mn
Mar 31, 2024 223.11 Mn
Dec 31, 2023 167.49 Mn
Sep 30, 2023 100.76 Mn
Jun 30, 2023 114.17 Mn
Mar 31, 2023 94.69 Mn
Dec 31, 2022 69.86 Mn
Sep 30, 2022 54.84 Mn
Jun 30, 2022 58.23 Mn
Mar 31, 2022 68.16 Mn
Dec 31, 2021 59.38 Mn
Sep 30, 2021 66.29 Mn
Mar 31, 2021 55.63 Mn